BIOCHEMICAL SOCIETY TRANSACTIONS (Petters et al., 1983) permits the determination of small amounts of 7-aminoclonazepam (about 20 pmol) and is thus useful for measuring low activities in various tissues. All investigated foetal livers catalysed the nitroreduction reaction at different rates. The mean activity was in the same range as that in Rhesus monkey liver, but only about 15% of the activity in human adult liver. Such discrepancies between foetal and adult livers are usually encountered for many drug-oxidation reactions.
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The enzyme reaction obeyed Michaelis-Menten kinetics and the apparent K , values are in reasonable agreement. The levels that are normally encountered in treated patients (Sjo et al., Stah1 et al., 1983) are far below these K , values, indicating that the enzymes are operating in uiuo under first-order conditions.
Our results are in agreement with the data of Juchau (1970 . In the presence of CO the reduction of clonazepam was almost completely inhibited. Omission of NADP yielded very low metabolic rates, indicating that this cofactor is required for the reaction. We also demonstrated an extreme sensitivity to O2 in that the presence of air in the incubation tubes inhibited the nitroreduction more than 95%. As far as the dependence on NADP and sensitivity to CO and O2 is concerned, the reaction conforms with the concepts of the microsomal nitroreductase (Gillette et al., 1968) and may thus be catalysed by cytochrome P-450.
Reduction reactions are catalysed not only in microsomes but also in the soluble fraction of the liver (Fouts & Brodie, 1957) . We did not investigate the reduction in the soluble fraction of the human foetal liver, but assume that is has less quantitative significance than the microsomal metabolism.
Nitroreductase activity in the homogenates of foetal hepatocyte cultures may thus be derived both from soluble and microsomal enzyme. The specific activity when based on total protein in the homogenate was only about 3% of microsomal activity, which is consistent with the dilution effect by non-microsomal protein.
Our study thus has shown that the human foetal liver contains a microsomal nitroreductase enzyme system which catalyses the reduction of clonazepam, an anti-epileptic drug. Although the metabolic rates are low in human foetuses and hence the quantitative importance of this enzyme for the foetal clearance of clonazepam is doubtful, its presence may have toxicological implications in the metabolism of other nitro compounds, since many sideeffects of drugs are thought to be mediated via the formation of N-oxygenated metabolites from amines (Uehleke, 1973 The placenta is an important organ pharmacologically and toxicologically, since it is the principal tissue controlling access of drugs and other foreign chemicals to the foetus (Juchau, 1980) . Consequently, the enzymology of placental xenobiotic metabolism shoud be elucidated, so that a clear understanding may be obtained of placental detoxication and metabolic activation. The placenta is also an important organ endocrinologically. Several steroid hormones are synthesized in the placenta, and two of the more important steps are catalysed by cytochrome P-450-associated enzymes, namely aromatase and the cholesterol-side-chaincleavage enzyme (Tulchinsky & Ryan, 1980) . It is important, therefore, to study possible relationships between xenobiotic-oxidizing and steroid-oxidizing cytochrome P-450 in the placenta. The placenta is also an interesting organ from the basic biochemical point of view. Placental aryl-hydrocarbon hydroxylase is inducible by maternal cigarette smoking (Welch et al., 1969; Nebert et al., 1969; Pelkonen et al., 1972) and this induction is characteriized by extreme interindividual variability and great magnitude in certain cases (Pelkonen et al., 1978; Gurtoo et al., 1983) . These features of course raise questions concerning the mechanism of induction and the relative contributions of genetic background and environmental influences to the induction.
In this paper we present first some current concepts on the enzymology of placental xenobiotic and steroid metabolism and then illustrate some unique aspects of the response of the placental xenobiotic metabolism to exogenous influences, thus serving as a possible starting point for in-depth molecular-biological studies.
Enzymology of placental xenobiotic and steroid oxidations
A tentative list of different cytochromes P-450 in human placenta and criteria for their differentiation are presented in Table 1 . It seems probable that two different cytochromes metabolizing 7-ethoxycoumarin exist. This conclusion must be drawn on the basis of enzyme-kinetic (Pelkonen & Moilanen, 1979) and aminoglutethimide-inhibition studies (Pasanen & Pelkonen, 1983) . The cytochrome P-450 associated with the cigarette-smoke-inducible aryl-hydrocarbon hydroxylase is probably the form which is responsible for 
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For original references, see Juchau (1976 Juchau ( , 1980 the metabolism of many other xenobiotic substrates as well, for example 2,5-diphenyloxazole (Pelkonen & Moilanen, 1979) , 7-ethoxyresorufin Manchester & Jacoby, 1981) , zoxazolamine (Kapitulnik et al., 1977) and 2-acetylaminofluorene (Juchau et al., 1975) . The last substrate is interesting since only some carbon hydroxylations seem to be catalysed by cigarette-smoke-inducible cytochrome P-450, whereas N-hydroxylation is catalysed by (a) different basal enzyme(s). Aromatase and cholesterol-side-chaincleavage enzyme can be differentiated from xenobioticmetabolizing enzymes by differential inhibitors (Zachariah & Juchau, 1977; Pasanen & Pelkonen, 1983) and by using an antibody prepared against the purified mitochondrial cytochrome P-450 (M. Pasanen & 0. Pelkonen, unpublished work) . There is also evidence that there are two different cytochromes P-450 with associated aromatase activity (Osawa & Higashiyama, 1980) . Oestrogen 2-and 4-hydroxylations have been studied by Juchau's group (Chao et al., 1981; Juchau et al., 1982) and has been suggested, on the basis of differential responses to inducers and inhibitors, to be different from other steroid-or xenobiotic-oxidizing enzymes. Very little is known about enzymes metabolizing 25-hydroxycholecalciferol, except that they are cytochrome P-450 forms which probably are different from other cytochromes present in placental mitochondria or microsomes (L. Koskinen, M. Pasanen & 0. Pelkonen, unpublished work). It seems that human placenta contains at least four reasonably characterized cytochromes P-450 participating in xenobiotic and steroid oxidations, but that the number of different isoenzymes could be much larger, perhaps up to ten.
Regulation of xenobiotic and steroid metabolism in placenta
Among classical inducers, cigarette smoke is the only one which is able to induce placental xenobiotic metabolism (Pelkonen, 1980; Juchau, 1980) . When compared with other tissues available from humans, placenta is clearly extraordinary in its response to maternal cigarette smoking (Table 2 ). In human liver no induction of aryl-hydrocarbon hydroxylase activity can be detected (Vahakangas et al., 1983) . In lungs, induction has been claimed to occur, but it is not certain in humans (Vahakangas et al., 1983) . Explanted or cultured tissues and cells seem to be somewhat different in that respect, since during culture they acquire the ability to be induced by the exposure to polycyclic aromatic hydrocarbon inducers (Pelkonen & Nebert, 1982) . Placental explants or cells are again an exception, because they lose that extraordinary inducibility of aryl-hydrocarbon hydroxylase during culturing . Lymphocytes have been used as an index tissue for measuring the inducibility of aryl-hydrocarbon hydroxylase activity in man. During culture, they seem to retain some 'memory' about the cigarette smoking in vivo, but mitogen exposure is still needed before induction can be studied at all (Karki et af., 1981) . All these tissue and culture differences make the placenta very attractive as a potential target for molecular-biological studies concerning the mechanism of induction by cigarette smoking in human tissues, but there still are a number of difficulties and obstacles before actual studies are feasible. One of the major difficulties thus far has been the inability to purily or even detect spectrally the benzo[a]pyrene-metabolizing cytochrome P-450 in placenta (Pelkonen & Pasanen, 1982; Pasanen & Pelkonen, 1983; Namkung et al., 1983) , one of the prerequisites for molecular-biological studies being a pure enzyme against which specific antibodies may be made.
Steroid oxidations are such an important part of the overall hormone metabolism during gestation that their regulation is expected to be much more stringently controlled than xenobiotic oxidations. Nevertheless, some studies suggest that environment also affects placental steroid metabolism. Juchau and co-workers demonstrated an inverse correlation between aryl-hydrocarbon hydroxylase and cholesterol side-chain cleavage in placentas from smokers (Juchau et al., 1972) . Aromatase activity also seems to be affected by maternal cigarette smoking, although the effect is probably more complex than simple inhibition or induction and seems to be dose-dependent (Pasanen & Pelkonen, 1983) . Catechol oestrogen formation is also stimulated by maternal cigarette smoking (Chao et af., 1981 ; Juchau et al., 1982) . These studies point to a possibility that although, basically, steroid metabolism is rather steadily regulated, exogenous pharmacological or toxi-cological influences may have some effects, the mechanisms of which remain to be elucidated.
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